Trajectory Alpha Acquisition Corp
Zalatoris Acquisition Corp. does not have significant operations. It focuses on effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify business opportunities in the field of technology-driven business. The company was formerly known as Trajectory A… Read more
Trajectory Alpha Acquisition Corp (TCOA) - Net Assets
Latest net assets as of September 2023: $58.56 Million USD
Based on the latest financial reports, Trajectory Alpha Acquisition Corp (TCOA) has net assets worth $58.56 Million USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($68.37 Million) and total liabilities ($9.81 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $58.56 Million |
| % of Total Assets | 85.65% |
| Annual Growth Rate | 0.17% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Trajectory Alpha Acquisition Corp - Net Assets Trend (2021–2022)
This chart illustrates how Trajectory Alpha Acquisition Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Trajectory Alpha Acquisition Corp (2021–2022)
The table below shows the annual net assets of Trajectory Alpha Acquisition Corp from 2021 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $170.04 Million | +0.17% |
| 2021-12-31 | $169.75 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Trajectory Alpha Acquisition Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 112168700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $175.64 Million | 103.29% |
| Total Equity | $170.04 Million | 100.00% |
Trajectory Alpha Acquisition Corp Competitors by Market Cap
The table below lists competitors of Trajectory Alpha Acquisition Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Helius Medical Technologies Inc Class A
NASDAQ:HSDT
|
$60.18 Million |
|
North European Oil Royalty Trust
NYSE:NRT
|
$60.20 Million |
|
iBio, Inc. Common Stock
NASDAQ:IBIO
|
$60.21 Million |
|
CSP Inc
NASDAQ:CSPI
|
$60.22 Million |
|
Daedong Gear Co. Ltd
KQ:008830
|
$60.14 Million |
|
Chin Hin Group Property Bhd
KLSE:7187
|
$60.12 Million |
|
ASSOCIATED CAP. A DL-001
F:41J
|
$60.11 Million |
|
Seoul City Gas
KO:017390
|
$60.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Trajectory Alpha Acquisition Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 169,746,446 to 170,040,322, a change of 293,876 (0.2%).
- Net income of 383,998 contributed positively to equity growth.
- Share repurchases of 335,000 reduced equity.
- New share issuances of 250,000 increased equity.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $384.00K | +0.23% |
| Share Repurchases | $335.00K | -0.2% |
| Share Issuances | $250.00K | +0.15% |
| Other Changes | $-5.12K | -0.0% |
| Total Change | $- | 0.17% |
Book Value vs Market Value Analysis
This analysis compares Trajectory Alpha Acquisition Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.33x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.33x to 1.33x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $32.20 | $10.51 | x |
| 2022-12-31 | $7.89 | $10.51 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Trajectory Alpha Acquisition Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.23%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.04x
- Recent ROE (0.23%) is above the historical average (0.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -0.12% | 0.00% | 0.00x | 1.04x | $-17.19 Million |
| 2022 | 0.23% | 0.00% | 0.00x | 1.04x | $-16.62 Million |
Industry Comparison
This section compares Trajectory Alpha Acquisition Corp's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Trajectory Alpha Acquisition Corp (TCOA) | $58.56 Million | -0.12% | 0.17x | $60.16 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |